⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX DEADLINE REMINDER: MoonLake Immunotherapeutics 90% Stock Drop Triggers Securities Fraud Class Action - Investors Urged to Contact BFA Law by December 15
accessnewswire.com
MLTX
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
Pomerantz LLP Informs Shareholders of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
accessnewswire.com
MLTX
Investor Alert: Deadline Approaching to Join MoonLake Immunotherapeutics (MLTX) Class Action - Contact Levi & Korsinsky
accessnewswire.com
MLTX
December 15, 2025 Deadline Approaching: Join Class Action Against MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) Investors - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Class Action Alert: Levi & Korsinsky Reminds MoonLake (MLTX) Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX